What’s New in Photon Counting CT?

August 22, 2026 · 4 articles · 5 research themes · covering August 15, 2026 – August 22, 2026

Overview

Across these studies, photon-counting detector CT (PCD/PCCT) is repeatedly shown to improve diagnostic specificity by leveraging spectral information—particularly virtual monoenergetic and iodine-related reconstructions. In pelvic imaging, virtual unenhanced (VUE) and iodine map reconstructions better separated enhancing from non-enhancing hyperdense adnexal lesions than conventional hyperdensity assessment alone. In bladder cancer, low-keV virtual monoenergetic images improved lesion-to-background contrast and supported more accurate evaluation of muscle invasion, strengthening the role of spectral reconstructions in local staging.

A second theme is practical expansion of advanced reconstruction methods into clinically feasible workflows. The carotid black-blood CT study demonstrated that a single-phase acquisition, combined with spectral iodine suppression and tuned iodine ratio settings, can enhance carotid vessel wall/plaque visualization without requiring multi-phase imaging. Finally, attention is also shifting toward patient-centered safety: the forearm point-of-care PCCT work used Monte Carlo–based organ absorbed dose estimation and spectral shaping (voltage/filtration) to reduce radiation exposure while maintaining image quality—moving beyond reliance on CTDI alone.

Together, the findings suggest a convergence of three priorities for next-generation CT: (1) spectral reconstructions that improve tissue characterization and staging, (2) acquisition/reconstruction strategies that fit real-world clinical constraints, and (3) more accurate, organ-relevant dose optimization to enable safer deployment of photon-counting CT technologies.

---

Photon-Counting CT for Oncologic Staging (Bladder Cancer and Beyond)

Photon-Counting CT With Low-keV Virtual Monoenergetic Images for Detecting Muscle Invasion in Bladder Cancer: A Prospective Study.

In this prospective study, patients with pathologically confirmed bladder cancer underwent preoperative photon-counting detector (PCD) CT, and the diagnostic performance of low-keV virtual monoenergetic images (VMIs at 40, 50, 60, and 70 keV) and T3D images was compared with conventional polychromatic images for detecting muscle invasion. The key finding was that low-keV VMIs on PCD CT provided improved lesion-to-background contrast and maintained acceptable image noise, leading to better assessment of muscle invasion than conventional polychromatic CT. Scientifically and clinically, this supports using PCD CT spectral reconstructions to enhance local staging accuracy in bladder cancer, potentially improving treatment planning.

Wang W, He J, Wu J et al. · AJR. American journal of roentgenology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT for Vascular Imaging (Carotid Plaque/Vessel Wall)

Spectral Black-Blood Photon-Counting CT for High-Resolution Carotid Vessel Wall Imaging: A Feasibility Study.

This IRB-approved retrospective feasibility study assessed a novel single-phase spectral black-blood photon-counting CT (BBCT) technique for high-resolution carotid vessel wall imaging in patients undergoing clinically indicated head-and-neck PCD-CT angiography (CTA), generating BBCT reconstructions from one angiographic phase using spectral iodine suppression. The key finding was that varying nine iodine ratio (IR) settings enabled a balance between intraluminal iodine suppression and preservation of carotid vessel wall signal, supporting improved plaque feature visualization. This is significant because it demonstrates a practical pathway to higher-resolution, plaque-focused carotid wall imaging using spectral BBCT without requiring multi-phase acquisitions.

Tóth A, Hagar MT, Halfmann MC et al. · Investigative radiology · (2026) · View on PubMed ↗

---

Radiation Dose Optimization and Organ-Absorbed Dose Estimation (PCCT/PCD CT)

Organ dose optimization for a point-of-care forearm X-ray photon-counting CT.

This study investigated organ dose optimization for a point-of-care forearm photon-counting CT system by applying spectral shaping (adjusting source voltage and filtration) and estimating organ absorbed doses rather than relying solely on CTDI, using Monte Carlo simulations. The key finding was that specific combinations of voltage and filtration could reduce radiation exposure while preserving image quality, with organ absorbed dose estimates enabling more patient-relevant optimization. Scientifically, it advances dose evaluation for extremity PCD CT and supports more accurate, organ-based radiation risk reduction strategies for point-of-care imaging.

Rodesch PA, Viry A, Khorsi M et al. · Computers in biology and medicine · (2026) · View on PubMed ↗ · Free PDF ↗

---

Imaging Biomarkers for Lesion Enhancement Characterization (Enhancing vs Non-Enhancing)

Distinguishing enhancing from non-enhancing hyperdense adnexal lesions with spectral reconstructions at photon counting CT.

This retrospective study evaluated whether photon-counting CT (PCCT) spectral reconstructions—specifically virtual unenhanced (VUE) and iodine map images—can distinguish enhancing from non-enhancing hyperdense adnexal lesions in adult women with lesions >1 cm and >20 Hounsfield units (HU) on 70 keV PCCT, using pelvic MRI or ultrasound within 180 days as the reference standard. The key finding was that PCCT spectral reconstructions improved characterization of hyperdense adnexal lesions by separating enhancing lesions from non-enhancing ones more effectively than conventional hyperdensity assessment alone. Clinically, this could reduce unnecessary follow-up imaging and improve triage of adnexal lesions detected on CT by leveraging PCCT iodine/VUE information.

Rigau D, Parrott D, Bansal B et al. · Abdominal radiology (New York) · (2026) · View on PubMed ↗

---

---

Generated automatically on August 22, 2026. Covers PubMed articles published August 15, 2026 – August 22, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.